Ai L, Xu A, Xu J. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.Adv Exp Med Biol. 2020;1248:33-59. doi:10.1007/978-981-15-3266-5_3 Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer.Am J Cancer Res. 2020;10(3):727-742. Published 2020...
该文围绕PD-1/PD-L1抑制剂的抗肿瘤机制以及不同类型mCRC患者的PD-1/PD-L1抑制剂临床应用进展和研究现状作一综述,探究PD-1/PD-L1抑制剂联合治疗的可行性,以期为错配修复完整/微卫星稳定型患者获益和优化PD-1/PD-L1抑制剂在mCRC治疗中的用药方案提供参考。 Abstract Colorectal cancer is currently one of ...
(8) Han, Y., Liu, D., & Li, L. (2020). PD-1/PD-L1 pathway: current researches in cancer. American journal of cancer research, 10(3), 727–742. (9) Frigault MJ, Armand P, Redd RA, Jeter E, Merryman RW, Coleman KC, Herrera AF, Dahi P, Nieto Y, LaCasce AS, Fisher DC...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020,10(3): 727-742. [2] Tang Q, Chen Y, Li X, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Imunol. 2022, 13: 964442...
L. (2020). PD-1/PD-L1 pathway: current researches in cancer. American journal of cancer resear...
8.Han Y, Liu D, LiL. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. 9.Managingtoxicities associated with immune checkpoint inhibitors: ...
8.Han Y, Liu D, LiL. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. 9.Managingtoxicities associated with immune checkpoint inhibitors: consensusrecommendations from the Society for Immunotherapy of Cancer (...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020,10(3): 727-742. [2] Tang Q, Chen Y, Li X, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in ...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer[J]. American Journal of Cancer Research, 2020, 10(3):727-742. [2] Attili I, Tarantino P, Passaro A, et al. Strategies to overc...
结论E2联合BaP可能通过异常激活AHR-AKT-ERK1/2信号通路诱导人肺腺癌A549细胞PD-L1表达升高。关键词 雌二醇;苯并芘;程序性死亡配体1;非小细胞肺癌;AHR-AKT-ERK1/2信号通路肺癌是常见的恶性肿瘤疾病,发病率在全球范围内持续上升,非小细胞...